Table 1.
Baseline characteristics of STEMI patients with and without MACE.
| All | Without MACE | With MACE | p-Value | |
|---|---|---|---|---|
| Patients, n | 659 | 549 | 110 | |
| Age (years) | 60 ± 12 | 58 ± 12 | 66 ± 12 | <0.001 |
| Male sex, n (%) | 532 (81) | 455 (83) | 77 (70) | 0.002 |
| Diabetes mellitus, n (%) | 146 (22) | 115 (21) | 31 (28) | 0.1 |
| Hypertension, n (%) | 324 (49) | 252 (46) | 72 (65) | <0.001 |
| Hypercholesterolemia, n (%) | 302 (46) | 250 (46) | 52 (47) | 0.7 |
| Smoker, n (%) | 371 (56) | 317 (58) | 54 (49) | 0.09 |
| Heart rate (beats per minute) | 78 ± 19 | 77 ± 19 | 84 ± 21 | <0.001 |
| Systolic blood pressure (mmHg) | 130 ± 30 | 131 ± 29 | 129 ± 33 | 0.6 |
| Creatinine (mg/dL) | 0.92 (0.8–1.1) | 0.91 (0.8–1.09) | 0.96 (0.8–1.18) | 0.1 |
| Glucose (mg/dL) | 130 (107–167) | 128 (105–161) | 148 (119–188) | <0.001 |
| Killip class >1 (%) | <0.001 | |||
| 1 | 549 (83) | 475 (87) | 74 (67) | |
| >1 | 110 (17) | 74 (13) | 36 (33) | |
| Time from chest pain to first medical contact (min) | 190 (130–300) | 180 (120–297) | 225 (160–420) | 0.002 |
| CK-MB mass peak value (ng/mL) | 164 (60–290) | 151 (57–278) | 196 (69–318) | 0.06 |
| Anterior infarction, n (%) | 332 (50) | 260 (47) | 72 (65) | 0.001 |
| TIMI flow grade before PCI (%) | 0.9 | |||
| 0 | 345 (52) | 286 (52) | 59 (54) | |
| 1 | 44 (7) | 36 (7) | 8 (7) | |
| 2 | 73 (11) | 63 (11) | 10 (9) | |
| 3 | 197 (30) | 164 (30) | 33 (30) | |
| TIMI flow grade after PCI (%) | 0.1 | |||
| 0 | 17 (3) | 12 (2) | 5 (4) | |
| 1 | 6 (1) | 4 (1) | 2 (2) | |
| 2 | 50 (7) | 37 (7) | 13 (12) | |
| 3 | 586 (89) | 496 (90) | 90 (82) | |
| Grace Risk Score | 135 ± 32 | 131 ± 29 | 160 ± 33 | <0.001 |
| Timi Risk Score | 2 (1–4) | 2 (1–4) | 4 (2–6) | <0.001 |
Abbreviations: CK-MB: creatine kinase myocardial band; MACE: major adverse cardiac events; STEMI: ST-segment elevation myocardial infarction; PCI: primary coronary intervention; TIMI: thrombolysis in myocardial infarction.